0 results for 'Wachtell, Lipton, Rosen & Katz'
Am Law 100 Analysis: The Superrich Firms Pull Away
It was a year of solid gains for The Am Law 100, especially for a burgeoning group of top firms.From the Editor: The Am Laws at 30
You're not getting older, you're getting better.The Am Law 100: Introducing Our New Profits Metric
To help add context to our reporting on law firm profits, this year's Am Law 100 report adds a new metric, profits per lawyer.Am Law 100 Analysis: The Superrich Firms Pull Away
It was a year of solid gains for The Am Law 100, especially for a burgeoning group of top firms.Top Activist Lawyer Lands on a New Team
Morgan Stanley has hired Schulte Roth & Zabel's David Rosewater, co-head of the firm's global shareholder activism practice, to lead its activist defense group. But Rosewater, who previously worked at Cravath, Swaine & Moore, won't be fighting Marty Lipton's war.Top Activist Lawyer Lands on a New Team
Morgan Stanley has hired Schulte Roth & Zabel's David Rosewater, co-head of the firm's global shareholder activism practice, to lead its activist defense group. But Rosewater, who previously worked at Cravath, Swaine & Moore, won't be fighting Marty Lipton's war.Litigation Department of the Year, Securities: Kirkland & Ellis
With help from Kirkland litigators, Pershing Square's push for an Allergan takeover worked out to the tune of $2.2 billion.Litigation Department of the Year, Securities: Kirkland & Ellis
With help from Kirkland litigators, Pershing Square's push for an Allergan takeover worked out to the tune of $2.2 billion.Deal Watch: Big Firm Pharma Deal Flow Continues With Teva's Mylan Bid
Big Pharma leads the list of billion-dollar deals this week with a $40 billion, unsolicited bid made by Israel's Teva Pharmaceutical Industries Ltd. for fellow generic-drug maker Mylan N.V.Deal Watch: Big Firm Pharma Deal Flow Continues With Teva's Mylan Bid
Big Pharma leads the list of billion-dollar deals this week with a $40 billion, unsolicited bid made by Israel's Teva Pharmaceutical Industries Ltd. for fellow generic-drug maker Mylan N.V.Corporate Transparency Act Resource Kit
Brought to you by Wolters Kluwer
Download Now
Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now